Addiction and buprenorphine treatment education |
TTA educates the staff on buprenorphine treatment through a day-long Buprenorphine-101 training. Additionally, knowledge regarding working with individuals with substance use disorders is disseminated, and continued support is provided as needed. Ongoing quarterly trainings address pertinent addiction-related topics for OBOT program staff. |
Program initiation and induction process |
Education through formalized training and shadowing at BMC’s OBOT/buprenorphine clinic, hands-on support is provided at the CHC, ongoing telephone and email support is offered as needed. |
Program integration into existing primary care setting |
TTA assists program integration into the FQHCs and provides quality control of the programs. |
Knowledge of Collaborative Care Model |
Formalized training on the model and the policy and procedure manual is provided during initial day-long training. Additionally training is provided to all staff involved in the buprenorphine program. |
NCM hiring and training |
Assisted with the hiring process via posting through addiction RN list serve distributed to addiction nurses throughout the state. |
Policy/procedure development |
A buprenorphine treatment policy and procedure manual was developed. This manual was provided to the CHCs in a word document so that each CHC could make site-specific changes and incorporate it into their day-to-day practice. |
Staff buy-in |
CHC staff are provided trainings related to treating individuals with addiction, ongoing support is offered, ongoing communication with staff facilitates understanding, and site-meetings are scheduled as needed. |
Stigma |
Education about the disease of addiction is provided to all staff involved and health center wide if agreeable. Sites are supported ongoing when questions and issues arise. |
Billing |
Educating about utilization of an NCM in a FQHCs in billing. |
Limited physician interest |
CHC physicians are engaged through education about treating the disease of addiction and the incorporation of this treatment into a primary care setting. |